Breakthrough HAE treatment enters final Long-Term testing phase
NCT ID NCT07428499
Summary
This study continues testing ADX-324, an experimental treatment for hereditary angioedema (HAE), to see how safe and effective it is over a longer period. It's for people who already completed the main trial and have HAE types 1 or 2. Researchers will track side effects, count how many HAE attacks participants have, and measure quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.